Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

15.74
-0.4800-2.96%
Post-market: 15.52-0.2231-1.42%19:10 EDT
Volume:1.22M
Turnover:19.22M
Market Cap:2.17B
PE:-13.85
High:16.11
Open:15.62
Low:15.54
Close:16.22
Loading ...

Arrowhead Pharmaceuticals : Bernstein Cuts Target Price to $17 From $24

THOMSON REUTERS
·
05 Jun

Arrowhead Pharmaceuticals Launches Phase 1/2a Clinical Trial of ARO-ALK7 for Obesity Treatment

Reuters
·
02 Jun

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of Aro-Alk7 for the Treatment of Obesity

THOMSON REUTERS
·
02 Jun

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Pharma Mar SA (OtherPHMMF)

TIPRANKS
·
27 May

Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
20 May

Stock Track | Arrowhead Pharmaceuticals Soars 10% Pre-market on Stellar Q2 Earnings, Beating Expectations

Stock Track
·
16 May

UBS Adjusts Price Target on Arrowhead Pharmaceuticals to $63 From $71, Maintains Buy Rating

MT Newswires Live
·
14 May

Arrowhead Shares Rise After 2Q Earnings Beat

Dow Jones
·
13 May

Stock Track | Arrowhead Pharmaceuticals Soars 12.74% on Stellar Q2 Earnings, Beating Expectations

Stock Track
·
13 May

Arrowhead Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
13 May

RBC Adjusts Price Target on Arrowhead Pharmaceuticals to $40 From $42, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
13 May

Arrowhead Pharmaceuticals: Hold Rating Amid Promising Developments and Regulatory Uncertainties

TIPRANKS
·
13 May

Arrowhead Pharmaceuticals : Citigroup Cuts Target Price to $17 From $21

THOMSON REUTERS
·
13 May

Hold Rating for Arrowhead Pharmaceuticals Amid Revenue Gains and Market Uncertainties

TIPRANKS
·
13 May

Stock Track | Arrowhead Pharmaceuticals Soars 10% Pre-market on Stellar Q2 Earnings, Beating Expectations

Stock Track
·
13 May

Stock Track | Arrowhead Pharmaceuticals Soars 10% Pre-Market on Stellar Q2 Earnings Beat

Stock Track
·
13 May

Arrowhead Pharmaceuticals : RBC Cuts Target Price to $40 From $42

THOMSON REUTERS
·
13 May

Arrowhead Pharmaceuticals Inc. Releases Transcript of Fiscal 2025 Second Quarter Conference Call

Reuters
·
13 May

Arrowhead Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Arrowhead Pharmaceuticals Swings to Fiscal Q2 Earnings; Shares Rise After Hours

MT Newswires Live
·
13 May